Roche Holding AG (LTS:0QOK)
CHF 263.05 -1.65 (-0.62%) Market Cap: 211.30 Bil Enterprise Value: 236.93 Bil PE Ratio: 19.78 PB Ratio: 7.21 GF Score: 86/100

Lonza Group AG Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche Holding AG Call Transcript

Mar 20, 2024 / 01:00PM GMT
Release Date Price: CHF229.88 (+0.43%)
Operator

Ladies and gentlemen, welcome to the Lonza Investor Conference Call and Live Webcast. I am Sandra, the Chorus Call operator. (Operator Instructions) The conference is being recorded. (Operator Instructions) The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to hand over to Mr. Albert M. Baehny, CEO at interim and Chairman of the Board of Directors. Please go ahead, sir.

Albert M. Baehny
Lonza Group AG - Interim CEO & Chairman

Thank you for the introduction. Good morning, good afternoon, and thanks to you all for joining the short update call about our agreement to acquire the Vacaville site from Roche. I'm joined today by our CFO, Philippe Deecke; and the President of our Biologics division, Jean-Christophe Hyvert. We will share a few details of the acquisition, then take some time to answer your questions. Let me provide a short overview of the transaction.

Today, we have signed an agreement with Roche to acquire the Genentech large-scale biologics facility in Vacaville, California, for USD 1.2

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot